Company Quick10K Filing
NL Industries
10-Q 2020-09-30 Filed 2020-11-04
10-Q 2020-06-30 Filed 2020-08-05
10-Q 2020-03-31 Filed 2020-05-06
10-K 2019-12-31 Filed 2020-03-11
10-Q 2019-09-30 Filed 2019-11-07
10-Q 2019-06-30 Filed 2019-08-07
10-Q 2019-03-31 Filed 2019-05-09
10-K 2018-12-31 Filed 2019-03-11
10-Q 2018-09-30 Filed 2018-11-07
10-Q 2018-06-30 Filed 2018-08-07
10-Q 2018-03-31 Filed 2018-05-08
10-K 2017-12-31 Filed 2018-03-12
10-Q 2017-09-30 Filed 2017-11-08
10-Q 2017-06-30 Filed 2017-08-08
10-Q 2017-03-31 Filed 2017-05-08
10-K 2016-12-31 Filed 2017-03-10
10-Q 2016-09-30 Filed 2016-11-07
10-Q 2016-06-30 Filed 2016-08-05
10-Q 2016-03-31 Filed 2016-05-06
10-K 2015-12-31 Filed 2016-03-10
10-Q 2015-09-30 Filed 2015-11-06
10-Q 2015-06-30 Filed 2015-08-07
10-Q 2015-03-31 Filed 2015-05-08
10-K 2014-12-31 Filed 2015-03-12
10-Q 2014-09-30 Filed 2014-11-07
10-Q 2014-06-30 Filed 2014-08-07
10-Q 2014-03-31 Filed 2014-05-08
10-K 2013-12-31 Filed 2014-03-12
10-Q 2013-09-30 Filed 2013-11-06
10-Q 2013-06-30 Filed 2013-08-07
10-Q 2013-03-31 Filed 2013-05-08
10-K 2012-12-31 Filed 2013-03-12
10-Q 2012-09-30 Filed 2012-11-06
10-Q 2012-06-30 Filed 2012-08-09
10-Q 2012-03-31 Filed 2012-05-09
10-K 2011-12-31 Filed 2012-03-06
10-Q 2011-09-30 Filed 2011-11-03
10-Q 2011-06-30 Filed 2011-08-03
10-Q 2011-03-31 Filed 2011-05-04
10-K 2010-12-31 Filed 2011-03-07
10-Q 2010-09-30 Filed 2010-11-01
10-Q 2010-06-30 Filed 2010-08-03
10-Q 2010-03-31 Filed 2010-05-04
10-K 2009-12-31 Filed 2010-03-10
8-K 2020-11-04
8-K 2020-10-29
8-K 2020-08-05
8-K 2020-05-21
8-K 2020-05-06
8-K 2020-04-22
8-K 2020-03-13
8-K 2020-03-11
8-K 2020-02-19
8-K 2019-11-07
8-K 2019-09-03
8-K 2019-08-07
8-K 2019-07-24
8-K 2019-07-16
8-K 2019-05-16
8-K 2019-05-16
8-K 2019-05-09
8-K 2019-03-18
8-K 2019-03-08
8-K 2018-11-07
8-K 2018-08-07
8-K 2018-05-17
8-K 2018-05-08
8-K 2018-03-15
8-K 2018-03-12

NL Industries Financials

NL Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546 323 0 0 0 0 -854
1 800 Flowers Com (FLWS) 944 42% 13.3 6% 665 336 1,266 534 37 75 1,001
10x Genomics (TXG) 4,805 75% -490.3 -2% 573 151 61 46 -10 -9 4,357
12 Retech (RETC) 0 32% -0.1 -1,385% 1 20 1 0 -15 -15 1
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 34 0% 0.4 -5% 164 108 18 0 -8 -8 -3
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 19 23 27 7 -3 -1 3
1895 Bancorp of Wisconsin (BCOW) 46,153 12,508.1 -0% 441 383 0 0 -0 4 46,142
1st Constitution Bancorp (FCCY) 165 0% 4.4 1% 1,343 1,204 0 0 14 33 144
1st Franklin Financial (FFC) 4 -0.6 7% 905 645 0 0 62 80 -46
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200 7.9 1% 6,691 5,858 0 0 70 136 1,073
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 2 0 0 -2 -2 0
21Vianet Group (VNET) 6,005 0% 11,151 5,788 0 0 0 0 3,344
22nd Century (XXII) 302 1% -14.1 -36% 62 7 26 0 -22 -21 302
1Life Healthcare (ONEM)

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash714125797873725253535873737383889695102101939395102103104116128121116132138
Accounts Receivable
Inventory21202020191911121213131516151717161515141415151515151516171717191819
PP&E181169170171467491522503508524878788898990919292949494959596969797989596969696
Assets7097577617592,1162,0362,0271,8601,7421,674686560534540501482435370349348354380385396457481552575591570547561591555
Accounts Payable86877854463556651055545555544465445
Long-Term Debt577137392833182802882030
Liabilities330352335339660577596601540573317271263263249235219192184183185194191192211216199204267259244241262232
Stockholders' Equity3683934154091,0541,1161,062982937920355275257263237233201164150149153170178187229248335353306292284300307301
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue353633365451,506397464908419222627262528292726272728263030272528323027313430
Cost of Revenue252725265341,496391458900412161818181719201818191919172020191819212020222320
Gross Profit10989111066886898899888899101087101110810119
R&D
SG&A666776-155544555555555555555555555
Tax11219830000010401-21-4-300-1-2220603-2031-2
Net Income17282021643521-2-14-6-334614510-291-6-21810942184915-42-153167-1
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating224-1659-255816161112071010285329217-2
Cash Investing-314-114-28231-0-1-1-1-1-1-0-2-1-0-11-17-2-112-2-04-6-17
Cash Financing9-40-5-17-1-21-7-6-24-6-0-0-0-0